English   español  
Por favor, use este identificador para citar o enlazar a este item: http://hdl.handle.net/10261/126252
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:

The leukocyte activation receptor CD69 controls T cell differentiation through its interaction with galectin-1

AutorFuente, Hortensia de la; Bonay, Pedro ; Sánchez-Madrid, Francisco
Fecha de publicación21-abr-2014
CitaciónMolecular and Cellular Biology 34: 2479- 2487 (2014)
ResumenCD69 is involved in immune cell homeostasis, regulating the T cell-mediated immune response through the control of Th17 cell differentiation. However, natural ligands for CD69 have not yet been described. Using recombinant fusion proteins containing the extracellular domain of CD69, we have detected the presence of a ligand(s) for CD69 on human dendritic cells (DCs). Pulldown followed by mass spectrometry analyses of CD69-binding moieties on DCs identified galectin-1 as a CD69 counterreceptor. Surface plasmon resonance and anti-CD69 blocking analyses demonstrated a direct and specific interaction between CD69 and galectin-1 that was carbohydrate dependent. Functional assays with both human and mouse T cells demonstrated the role of CD69 in the negative effect of galectin-1 on Th17 differentiation. Our findings identify CD69 and galectin-1 to be a novel regulatory receptor-ligand pair that modulates Th17 effector cell differentiation and function. © 2014, American Society for Microbiology.
Identificadoresdoi: 10.1128/MCB.00348-14
issn: 1098-5549
Aparece en las colecciones: (CBM) Artículos
Ficheros en este ítem:
Fichero Descripción Tamaño Formato  
SánchezMadrid_TheLeukocyteActivationReceptor.pdf1,93 MBAdobe PDFVista previa
Mostrar el registro completo

Artículos relacionados:

NOTA: Los ítems de Digital.CSIC están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.